Privacy, Policy and Legal Issues > Public Policy Initiatives

Oral chemotherapy has become the standard of care for many types of cancer. Importantly, most cancer therapies taken by mouth do not have IV or injected alternatives, and are the only option for some patients. Act Now to ask your lawmakers to support the Cancer Drug Coverage Parity Act, federal legislation that will ensure equal insurance coverage of cancer treatments regardless of how they are administered.

October 27, 2021 - The FDA released new guidance on breast implant labeling and communication today, recommending a 'black box warning,' addition of a decision checklist in the patient brochure, and new implant rupture screening guidelines, changing the timeline and adding ultrasound as an alternative to breast MRI.

PALS (Protecting Access to Lifesaving Screening) Act - H.R. 2412 / S. 4612

Originally enacted in 2015, reauthorization of the PALS Act is necessary to ensure that annual mammograms for women starting at age 40 will remain covered by health insurers with no cost to the patient. Access to these life-saving breast screenings is crucial!

Reducing Hereditary Cancer Act of 2021 - H.R. 4110

Medicare covers genetic testing only for people already diagnosed with cancer. For previvors with an inherited mutation, coverage of many high-risk cancer screenings or risk-reducing surgeries is prohibited by law. This legislation will modify the Medicare statutes to remedy these issues.

Genetic counselors provide crucial information and expertise. But, did you know that these knowledgeable providers are not approved Medicare practitioners? The Access to Genetic Counselor Services Act (H.R. 2144/
S. 1450) aims to remedy this issue. Join FORCE and the National Society of Genetic Counselors to support coverage of genetic counseling for Medicare beneficiaries and expanded access to genetic counseling services for all Americans.

Comments on New Colorectal Cancer Screening Recommendations

February 3, 2021 – Today, FORCE asked the U.S. Preventive Services Task Force (USPSTF) to develop Lynch syndrome screening recommendations to identify individuals at increased risk of colorectal and related cancers. This follows recent comments on its updated draft colorectal cancer screening guidelines.

Take Action Now 2021 Priorities Advocacy Archive

News Briefs

11/15/2021 - Joined over 150 orgs to urge passage of the DIVERSE Trials Act, which will make it easier for patients to participate in clinical trials and remove barriers that keep certain populations from being appropriately represented.

11/12/2021 - Submitted comments on the "Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms" policy proposed by Medicare's National Government Services, Inc. contractor.

11/1/2021 - Sent the Massachusetts Joint Committee on Financial Services a letter in support of S.640/H.1116, legislation that would require insurance coverage of fertility preservation for state residents facing a medical diagnosis or treatment that can impair their fertility.

10/26/2021 - An Alabama FORCE representative contacted the state's Medicaid leadership urging coverage of BRCA genetic testing, highlighting the fact that its program is the only one in the U.S. that doesn't cover this screening.

More


Sponsored By:

Genetech Merck